Events

We are incredibly grateful to everyone who visited our booth at the BioAsia 2024 on July 26-29 . As Alzheimer's disease garners increasing attention, people are excited about how our groundbreaking technology can aid in the early detection of this condition. Additionally, we showcased our iNA Embedded NGS Precision Medicine System. This system enables in-house precision medicine, providing faster and more accurate diagnostic reports, and facilitating personalized health management and treatment plans. 

Excited to be invited to give a talk in the USA!By harnessing the capabilities of our ultra-sensitive, real-time immunoassay that operates within the range of pg/ml to fg/ml, we’re accelerating the pace of advancements in life sciences research, drug development, and precision healthcare. Our Light Sensing Biomarker Analyzer/Reader, developed on the foundation of our patented FOPPR (Fiber Optic Particle Plasmon Resonance) and IN-Chip (auto-flowing microfluidics chip) technology, sets a new benchmark for biomarker “Analysis” and “Detection”.Date & Time: 12:00pm - 1:00pm EDT Location: UF Innovate | Sid Martin BioTech, 12085 Research Dr, Alachua, FL 32615Lunch ProvidedRegister here: https://reurl.cc/qV7G3q

We are excited to share the significant strides we have made through our collaboration with ALZpath, presented at the Tau2024 Global Conference. This partnership marks a pivotal moment in advancing Alzheimer's research, leveraging our innovative Fiber Optic Particle Plasmon Resonance (FOPPR) technology to develop pTau-217 assay.

We were captivated by Madison Honey's remarkable lecture at the AD/PD 2024 Symposium. As a researcher from Prof. Charlotte Teunissen's Neurochemistry Lab at Amsterdam UMC, she presented a lecture titled "Development of a prototype point-of-care test using FOPPR technology for ultrasensitive detection of Neurofilament Light Chain in plasma."Madison demonstrated the use of Instant NanoBiosensors' FOPPR technology, covering everything from antibody selection and analysis to ultra-sensitive plasma testing. This is not only a paradigm of technological innovation but also brings new light to the diagnosis and research of neurodegenerative diseases. The potential of this technology will undoubtedly have a profound impact on our understanding and treatment of neurodegenerative diseases.Information on: https://adpd2024.kenes.com/The AD/PD Conference is a prestigious event where leading experts convene to delve into the newest research, clinical trials, and treatments for Alzheimer’s and Parkinson’s diseases. It offers a platform for revealing groundbreaking discoveries and discussing the latest advancements in therapies.The Conference offers a great opportunity to connect with and learn from top international experts, discuss the latest news and trends in the field, and present your work to receive valuable feedback.

We are proud to announce our company's participation in Alzheimer's Association International Conference (AAIC) 2023 organized by the Alzheimer's Association.We would like to thank to everyone for taking their time to visit our booth (#111), at AAIC23.Our booth presented our innovative Biomarker Analyzers, Biomarker Analysis and Ultra-High Sensitivity Detection. Our in-depth conversations and exchange of real-world experiences are a testament to the potential that lies in our FOPPR's One-Stop Solution. We are very excited to see how our innovative tools can continue to drive your research forward.Information on Alzheimer's Association International Conference:AAIC is the largest and most influential meeting dedicated to advancing dementia science. AAIC is a five-day event that is defined by a diverse scientific program, which is shaped by your work and for your work.Each year, AAIC convenes researchers, clinicians, and dementia professionals from all career stages to share breaking research discoveries that will lead to methods of prevention and treatment and improvements in diagnosis for Alzheimer's disease. From basic science to dementia care, every aspect of the the related growing knowledge of dementia is incorporated into this world-class conference.